Insomnia Market - Industry Structure Evaluation, Demand Drivers Analysis, Regional Growth Analysis and Identification, Competitive Positioning Review & Global Market Size Forecast to 2034

4.2%
CAGR (2026-2034)
5.67 USD Bn.
Forecast Market Size
314
Report Pages
140
Market Tables

Overview

The Insomnia Market size was valued at USD 5.67 Billion in 2025 and the total Insomnia revenue is expected to grow at a CAGR of 4.2% from 2026 to 2034, reaching nearly USD 8.21 Billion.

Global Insomnia Market Overview:

Insomnia is a sleeping problem that affects people of all ages. Insomnia is also a term used to describe someone who has problems sleeping. This might exist in its own right or in combination with other psychological problems. Insomnia is more common in women than in men, and it is more likely to occur throughout life stages such as pregnancy and after childbirth, as well as the menopausal cycle. The specific origin of sleeplessness, however, remains a secret.

Insomnia Market Analysis from 2025 to 2034

Insomnia Market Growth

To know about the Research Methodology :- Request Free Sample Report

Global Insomnia Market Dynamics:

An increasing in the launch of new sleep-inducing drugs, devices, and treatments is anticipated to drive the insomnia market growth. For example, the Insomnia Clinic in Bloomsbury has developed a new treatment for insomnia. The clinical trials for the Insomnia showed positive results where 80% of the patients displayed remarkable improvements. Likewise, Eisai Inc has developed a drug called lemborexant (dual orexin receptor antagonist), adual orexin receptor antagonist that anticipated to be effective for the treatment of the older population with insomnia. Positive results and low price of devices are predictable to be the major factors promoting demand for devices.

Insomnia therapeutic devices have started gaining traction in developed countries such as Norway, Switzerland, Australia and Ireland. Medical devices have benefits like the fast onset of sleep and longer sleep maintenance among patients who have negative results through drugs. New technical devices like Alpha-Stim AID, Ebb Insomnia Therapy, and Fisher Wallace Stimulator have already received approvals from FDA. The Lemborexant, a novel Orexin Receptor Antagonist (ORA) by Eisai is anticipated to be launched in the early phase during forecast period.

Manufacturers in the Insomnia are focusing on competitive pricing as the strategy to capture significant market share. Moreover, strategic mergers and acquisitions and technological innovations are also the key focus areas of the manufacturers.

Global Insomnia Market Segment Analysis:

The global Insomnia Market is segmented by Treatment Type and Non-pharmacological Treatment.

Based on Treatment Type, the global Insomnia market is segmented into Non-pharmacological Treatment and Pharmacological Treatment. The pharmacological treatment is further sub-segmented into prescription sleep aids and over-the-counter sleep aids. The over-the-counter sleep aids is expected to grow at a highest CAGR of xx% in the global insomnia market during the forecast period. As comparison to prescription sleep medications, due to its easy accessibility and lower cost As per research statistics, utilising over-the-counter sleep medications will save a patient up to USD 47 each week.

Global Insomnia Market Regional Insights:

North America dominate the global Insomnia market during the forecast period 2026-2034. North America held the largest market share xx% in 2025. Asia Pacific without Japan is also expected to be a dominant region for the insomnia market’s growth. The reason for this is attributable to the increasing shift-related work in this region causing numerous sleep disorders. The rising urban population in this region has also driven the market’s expansion. Indonesia, India, and China are expected to be leading regions for the market’s growth in this region. According to Centers for Disease Control and Prevention (CDCP), approximately xx million adults in the United State suffered from insomnia disease. This is a result of the unhealthy lifestyle and rising stress levels among the population. Apart from the U.S., Canada has also highly contributed to the insomnia market’s growth in this region.

The objective of the report is to present a comprehensive analysis of the global Insomnia Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants.

PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.

The reports also helps in understanding the global Insomnia Market dynamic, structure by analyzing the market segments and project the global Insomnia Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the global Insomnia Market make the report investor’s guide.

Insomnia Market Recent Industry Developments

Date Company Development Impact
12 January 2025 Idorsia Ltd. Idorsia announced expanded European commercialization data for **daridorexant**, highlighting sustained efficacy in adult chronic insomnia patients over a **12-month** treatment duration. This milestone reinforces clinician confidence in long-term treatment safety and supports broader **market penetration** across Western Europe.
18 March 2025 Eisai Co. Ltd. Eisai published new phase 4 clinical findings on **lemborexant**, demonstrating superior sleep onset maintenance compared to standard controls in elderly insomnia cohorts. The study strengthens the drug's label profile, driving increased prescription volume among **geriatric specialists** globally.
14 May 2025 Big Health Ltd. Big Health secured a strategic distribution agreement with a major U.S. health plan to provide its digital cognitive behavioral therapy app, **Sleepio**, to over **2 million** covered lives. This partnership accelerates non-pharmacological insomnia therapy adoption and expands scalable digital therapeutic **revenue streams**.
22 August 2025 ResMed Inc. ResMed launched its next-generation connected sleep monitoring accessory integrated with advanced **AI-driven** analytics designed to detect comorbid sleep apnea and insomnia symptoms. The launch enhances diagnostic precision at home, boosting hardware **efficiency** and user engagement metrics.
10 November 2025 Merck & Co. Inc. Merck completed a comprehensive real-world evidence analysis confirming the sustained safety profile of legacy wake-fulness treatments, supporting a stable **5%** portfolio revenue growth. It solidifies the company's entrenched market position amidst rising competition from novel **orexin receptor antagonists**.
04 February 2026 Jazz Pharmaceuticals plc Jazz Pharmaceuticals announced the initiation of a rolling submission pathway for an investigational low-sodium oxybate formulation targeting severe sleep disruption tied to chronic insomnia. Successful progression paves the way for a potential regulatory approval and commercial launch by late **2026**.

Global Insomnia Market Scope: Inquire before buying

Global Insomnia Market
Report Coverage Details
Base Year: 2025 Forecast Period: 2026-2034
Historical Data: 2020 to 2025 Market Size in 2025: USD 5.67 Bn.
Forecast Period 2026 to 2034 CAGR: 4.2% Market Size in 2034: USD 8.21 Bn.
Segments Covered: by Treatment Type Non-Pharmacological Treatment

Pharmacological Treatment

Prescription Sleep Aids

 Over-the-Counter Sleep Aids
by Therapy Cognitive Behavioral Therapy for Isomnia
Hypnotherapy
Other Alternative Therapies
by Drug Class Antidepressants
Melatonin Antagonist
Benzodiazepines
Nonbenzodiazepines
Orexin Antagonist
Others
by Distribution Channel Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online Pharmacies

Global Insomnia Market, by Region

North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)

Key Players

1. Pfizer Inc.
2. Merck & Co. Inc.
3. Sanofi S.A.
4. GlaxoSmithKline plc
5. Takeda Pharmaceutical Company Limited
6. Koninklijke Philips N.V.
7. Viatris Inc.
8. Astellas Pharma Inc.
9. Sun Pharmaceutical Industries Limited
10. Eisai Co. Ltd.
11. Idorsia Ltd.
12. Teva Pharmaceutical Industries Ltd.
13. Dr. Reddy's Laboratories Ltd.
14. Big Health Ltd.
15. Vanda Pharmaceuticals Inc.
16. Sumitomo Pharma Co. Ltd.
17. Jazz Pharmaceuticals plc
18. Aurobindo Pharma Limited
19. Cipla Inc.
20. Zydus Lifesciences Limited
21. Lupin Limited
22. Mallinckrodt Pharmaceuticals
23. Fisher & Paykel Healthcare Corporation Limited
24. ResMed Inc.
25. Sunovion Pharmaceuticals Inc.
26. Casper Sleep Inc.
27. Biocodex Inc.
28. SleepScore Labs
29. Paratek Pharmaceuticals Inc.
30. Ebb Therapeutics

Frequently Asked Questions:

1] What segments are covered in Market report?
Ans.The segments covered in Insomnia Market report are based on Prescription Sleep Aids, Over-the-Counter Sleep Aids, and Non-pharmacological Treatment.

2] Which region is expected to hold the highest share in the global Market?
Ans. North America is expected to hold the highest share in the global Insomnia Market.

3] What is the market size of global Market by 2034?
Ans. The market size of global Insomnia Market by 2034 is USD 8.21 Bn.

4] Who are the top key players in the global Insomnia Market?
Ans. Astellas, Biocodex S A, Consumer Healthcare Inc., Dainippon Sumitomo, ECR Pharmaceuticals, and Eisai Co. are the top key players in the global Insomnia Market.

5] What was the Global Insomnia Market size in 2025?
Ans: The Global Insomnia Market size was USD 5.67 Billion in 2025.

6] By Non-pharmacological Treatment, What segments are covered in Insomnia Market report?
Ans. The segments covered in Insomnia Market report by Non-pharmacological Treatment, are Cognitive Behavioral Therapy for Insomnia (CBTI), Hypnotherapy and Other Alternative Therapies.

Table of Contents

1. Insomnia Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Global Insomnia Market: Competitive Landscape 2.1. MMR Competition Matrix 2.2. Competitive Landscape 2.3. Key Players Benchmarking 2.3.1. Company Name 2.3.2. Business Segment 2.3.3. End-user Segment 2.3.4. Revenue (2025) 2.3.5. Company Locations 2.4. Leading Insomnia Market Companies, by market capitalization 2.5. Market Structure 2.5.1. Market Leaders 2.5.2. Market Followers 2.5.3. Emerging Players 2.6. Mergers and Acquisitions Details 3. Insomnia Market: Dynamics 3.1. Insomnia Market Trends by Region 3.1.1. North America Insomnia Market Trends 3.1.2. Europe Insomnia Market Trends 3.1.3. Asia Pacific Insomnia Market Trends 3.1.4. Middle East and Africa Insomnia Market Trends 3.1.5. South America Insomnia Market Trends 3.2. Insomnia Market Dynamics by Region 3.2.1. North America 3.2.1.1. North America Insomnia Market Drivers 3.2.1.2. North America Insomnia Market Restraints 3.2.1.3. North America Insomnia Market Opportunities 3.2.1.4. North America Insomnia Market Challenges 3.2.2. Europe 3.2.2.1. Europe Insomnia Market Drivers 3.2.2.2. Europe Insomnia Market Restraints 3.2.2.3. Europe Insomnia Market Opportunities 3.2.2.4. Europe Insomnia Market Challenges 3.2.3. Asia Pacific 3.2.3.1. Asia Pacific Insomnia Market Drivers 3.2.3.2. Asia Pacific Insomnia Market Restraints 3.2.3.3. Asia Pacific Insomnia Market Opportunities 3.2.3.4. Asia Pacific Insomnia Market Challenges 3.2.4. Middle East and Africa 3.2.4.1. Middle East and Africa Insomnia Market Drivers 3.2.4.2. Middle East and Africa Insomnia Market Restraints 3.2.4.3. Middle East and Africa Insomnia Market Opportunities 3.2.4.4. Middle East and Africa Insomnia Market Challenges 3.2.5. South America 3.2.5.1. South America Insomnia Market Drivers 3.2.5.2. South America Insomnia Market Restraints 3.2.5.3. South America Insomnia Market Opportunities 3.2.5.4. South America Insomnia Market Challenges 3.3. PORTER's Five Forces Analysis 3.4. PESTLE Analysis 3.5. Technology Roadmap 3.6. Regulatory Landscape by Region 3.6.1. North America 3.6.2. Europe 3.6.3. Asia Pacific 3.6.4. Middle East and Africa 3.6.5. South America 3.7. Key Opinion Leader Analysis For Insomnia Industry 3.8. Analysis of Government Schemes and Initiatives For Insomnia Industry 3.9. Insomnia Market Trade Analysis 3.10. The Global Pandemic Impact on Insomnia Market 4. Insomnia Market: Global Market Size and Forecast by Segmentation (in USD Billion) 2025-2034 4.1. Insomnia Market Size and Forecast, by Treatment Type (2025-2034) 4.1.1. Non-Pharmacological Treatment 4.1.2. Over-the-Counter Sleep Aids 4.2. Insomnia Market Size and Forecast, by Therapy (2025-2034) 4.2.1. Cognitive Behavioral Therapy for Isomnia 4.2.2. Hypnotherapy 4.2.3. Other Alternative Therapies 4.3. Insomnia Market Size and Forecast, by Drug Class (2025-2034) 4.3.1. Antidepressants 4.3.2. Melatonin Antagonist 4.3.3. Benzodiazepines 4.3.4. Nonbenzodiazepines 4.3.5. Orexin Antagonist 4.3.6. Others 4.4. Insomnia Market Size and Forecast, by Distribution Channel (2025-2034) 4.4.1. Hospital Pharmacies 4.4.2. Retail Pharmacies 4.4.3. Drug Stores 4.4.4. Online Pharmacies 4.5. Insomnia Market Size and Forecast, by Region (2025-2034) 4.5.1. North America 4.5.2. Europe 4.5.3. Asia Pacific 4.5.4. Middle East and Africa 4.5.5. South America 5. North America Insomnia Market Size and Forecast by Segmentation (in USD Billion) 2025-2034 5.1. North America Insomnia Market Size and Forecast, by Treatment Type (2025-2034) 5.1.1. Non-Pharmacological Treatment 5.1.2. Over-the-Counter Sleep Aids 5.2. North America Insomnia Market Size and Forecast, by Therapy (2025-2034) 5.2.1. Cognitive Behavioral Therapy for Isomnia 5.2.2. Hypnotherapy 5.2.3. Other Alternative Therapies 5.3. North America Insomnia Market Size and Forecast, by Drug Class (2025-2034) 5.3.1. Antidepressants 5.3.2. Melatonin Antagonist 5.3.3. Benzodiazepines 5.3.4. Nonbenzodiazepines 5.3.5. Orexin Antagonist 5.3.6. Others 5.4. North America Insomnia Market Size and Forecast, by Distribution Channel (2025-2034) 5.4.1. Hospital Pharmacies 5.4.2. Retail Pharmacies 5.4.3. Drug Stores 5.4.4. Online Pharmacies 5.5. North America Insomnia Market Size and Forecast, by Country (2025-2034) 5.5.1. United States 5.5.1.1. United States Insomnia Market Size and Forecast, by Treatment Type (2025-2034) 5.5.1.1.1. Non-Pharmacological Treatment 5.5.1.1.2. Over-the-Counter Sleep Aids 5.5.1.2. United States Insomnia Market Size and Forecast, by Therapy (2025-2034) 5.5.1.2.1. Cognitive Behavioral Therapy for Isomnia 5.5.1.2.2. Hypnotherapy 5.5.1.2.3. Other Alternative Therapies 5.5.1.3. United States Insomnia Market Size and Forecast, by Drug Class (2025-2034) 5.5.1.3.1. Antidepressants 5.5.1.3.2. Melatonin Antagonist 5.5.1.3.3. Benzodiazepines 5.5.1.3.4. Nonbenzodiazepines 5.5.1.3.5. Orexin Antagonist 5.5.1.3.6. Others 5.5.1.4. United States Insomnia Market Size and Forecast, by Distribution Channel (2025-2034) 5.5.1.4.1. Hospital Pharmacies 5.5.1.4.2. Retail Pharmacies 5.5.1.4.3. Drug Stores 5.5.1.4.4. Online Pharmacies 5.5.2. Canada 5.5.2.1. Canada Insomnia Market Size and Forecast, by Treatment Type (2025-2034) 5.5.2.1.1. Non-Pharmacological Treatment 5.5.2.1.2. Over-the-Counter Sleep Aids 5.5.2.2. Canada Insomnia Market Size and Forecast, by Therapy (2025-2034) 5.5.2.2.1. Cognitive Behavioral Therapy for Isomnia 5.5.2.2.2. Hypnotherapy 5.5.2.2.3. Other Alternative Therapies 5.5.2.3. Canada Insomnia Market Size and Forecast, by Drug Class (2025-2034) 5.5.2.3.1. Antidepressants 5.5.2.3.2. Melatonin Antagonist 5.5.2.3.3. Benzodiazepines 5.5.2.3.4. Nonbenzodiazepines 5.5.2.3.5. Orexin Antagonist 5.5.2.3.6. Others 5.5.2.4. Canada Insomnia Market Size and Forecast, by Distribution Channel (2025-2034) 5.5.2.4.1. Hospital Pharmacies 5.5.2.4.2. Retail Pharmacies 5.5.2.4.3. Drug Stores 5.5.2.4.4. Online Pharmacies 5.5.3. Mexico 5.5.3.1. Mexico Insomnia Market Size and Forecast, by Treatment Type (2025-2034) 5.5.3.1.1. Non-Pharmacological Treatment 5.5.3.1.2. Over-the-Counter Sleep Aids 5.5.3.2. Mexico Insomnia Market Size and Forecast, by Therapy (2025-2034) 5.5.3.2.1. Cognitive Behavioral Therapy for Isomnia 5.5.3.2.2. Hypnotherapy 5.5.3.2.3. Other Alternative Therapies 5.5.3.3. Mexico Insomnia Market Size and Forecast, by Drug Class (2025-2034) 5.5.3.3.1. Antidepressants 5.5.3.3.2. Melatonin Antagonist 5.5.3.3.3. Benzodiazepines 5.5.3.3.4. Nonbenzodiazepines 5.5.3.3.5. Orexin Antagonist 5.5.3.3.6. Others 5.5.3.4. Mexico Insomnia Market Size and Forecast, by Distribution Channel (2025-2034) 5.5.3.4.1. Hospital Pharmacies 5.5.3.4.2. Retail Pharmacies 5.5.3.4.3. Drug Stores 5.5.3.4.4. Online Pharmacies 6. Europe Insomnia Market Size and Forecast by Segmentation (in USD Billion) 2025-2034 6.1. Europe Insomnia Market Size and Forecast, by Treatment Type (2025-2034) 6.2. Europe Insomnia Market Size and Forecast, by Therapy (2025-2034) 6.3. Europe Insomnia Market Size and Forecast, by Drug Class (2025-2034) 6.4. Europe Insomnia Market Size and Forecast, by Distribution Channel (2025-2034) 6.5. Europe Insomnia Market Size and Forecast, by Country (2025-2034) 6.5.1. United Kingdom 6.5.1.1. United Kingdom Insomnia Market Size and Forecast, by Treatment Type (2025-2034) 6.5.1.2. United Kingdom Insomnia Market Size and Forecast, by Therapy (2025-2034) 6.5.1.3. United Kingdom Insomnia Market Size and Forecast, by Drug Class (2025-2034) 6.5.1.4. United Kingdom Insomnia Market Size and Forecast, by Distribution Channel (2025-2034) 6.5.2. France 6.5.2.1. France Insomnia Market Size and Forecast, by Treatment Type (2025-2034) 6.5.2.2. France Insomnia Market Size and Forecast, by Therapy (2025-2034) 6.5.2.3. France Insomnia Market Size and Forecast, by Drug Class (2025-2034) 6.5.2.4. France Insomnia Market Size and Forecast, by Distribution Channel (2025-2034) 6.5.3. Germany 6.5.3.1. Germany Insomnia Market Size and Forecast, by Treatment Type (2025-2034) 6.5.3.2. Germany Insomnia Market Size and Forecast, by Therapy (2025-2034) 6.5.3.3. Germany Insomnia Market Size and Forecast, by Drug Class (2025-2034) 6.5.3.4. Germany Insomnia Market Size and Forecast, by Distribution Channel (2025-2034) 6.5.4. Italy 6.5.4.1. Italy Insomnia Market Size and Forecast, by Treatment Type (2025-2034) 6.5.4.2. Italy Insomnia Market Size and Forecast, by Therapy (2025-2034) 6.5.4.3. Italy Insomnia Market Size and Forecast, by Drug Class (2025-2034) 6.5.4.4. Italy Insomnia Market Size and Forecast, by Distribution Channel (2025-2034) 6.5.5. Spain 6.5.5.1. Spain Insomnia Market Size and Forecast, by Treatment Type (2025-2034) 6.5.5.2. Spain Insomnia Market Size and Forecast, by Therapy (2025-2034) 6.5.5.3. Spain Insomnia Market Size and Forecast, by Drug Class (2025-2034) 6.5.5.4. Spain Insomnia Market Size and Forecast, by Distribution Channel (2025-2034) 6.5.6. Sweden 6.5.6.1. Sweden Insomnia Market Size and Forecast, by Treatment Type (2025-2034) 6.5.6.2. Sweden Insomnia Market Size and Forecast, by Therapy (2025-2034) 6.5.6.3. Sweden Insomnia Market Size and Forecast, by Drug Class (2025-2034) 6.5.6.4. Sweden Insomnia Market Size and Forecast, by Distribution Channel (2025-2034) 6.5.7. Austria 6.5.7.1. Austria Insomnia Market Size and Forecast, by Treatment Type (2025-2034) 6.5.7.2. Austria Insomnia Market Size and Forecast, by Therapy (2025-2034) 6.5.7.3. Austria Insomnia Market Size and Forecast, by Drug Class (2025-2034) 6.5.7.4. Austria Insomnia Market Size and Forecast, by Distribution Channel (2025-2034) 6.5.8. Rest of Europe 6.5.8.1. Rest of Europe Insomnia Market Size and Forecast, by Treatment Type (2025-2034) 6.5.8.2. Rest of Europe Insomnia Market Size and Forecast, by Therapy (2025-2034) 6.5.8.3. Rest of Europe Insomnia Market Size and Forecast, by Drug Class (2025-2034) 6.5.8.4. Rest of Europe Insomnia Market Size and Forecast, by Distribution Channel (2025-2034) 7. Asia Pacific Insomnia Market Size and Forecast by Segmentation (in USD Billion) 2025-2034 7.1. Asia Pacific Insomnia Market Size and Forecast, by Treatment Type (2025-2034) 7.2. Asia Pacific Insomnia Market Size and Forecast, by Therapy (2025-2034) 7.3. Asia Pacific Insomnia Market Size and Forecast, by Drug Class (2025-2034) 7.4. Asia Pacific Insomnia Market Size and Forecast, by Distribution Channel (2025-2034) 7.5. Asia Pacific Insomnia Market Size and Forecast, by Country (2025-2034) 7.5.1. China 7.5.1.1. China Insomnia Market Size and Forecast, by Treatment Type (2025-2034) 7.5.1.2. China Insomnia Market Size and Forecast, by Therapy (2025-2034) 7.5.1.3. China Insomnia Market Size and Forecast, by Drug Class (2025-2034) 7.5.1.4. China Insomnia Market Size and Forecast, by Distribution Channel (2025-2034) 7.5.2. S Korea 7.5.2.1. S Korea Insomnia Market Size and Forecast, by Treatment Type (2025-2034) 7.5.2.2. S Korea Insomnia Market Size and Forecast, by Therapy (2025-2034) 7.5.2.3. S Korea Insomnia Market Size and Forecast, by Drug Class (2025-2034) 7.5.2.4. S Korea Insomnia Market Size and Forecast, by Distribution Channel (2025-2034) 7.5.3. Japan 7.5.3.1. Japan Insomnia Market Size and Forecast, by Treatment Type (2025-2034) 7.5.3.2. Japan Insomnia Market Size and Forecast, by Therapy (2025-2034) 7.5.3.3. Japan Insomnia Market Size and Forecast, by Drug Class (2025-2034) 7.5.3.4. Japan Insomnia Market Size and Forecast, by Distribution Channel (2025-2034) 7.5.4. India 7.5.4.1. India Insomnia Market Size and Forecast, by Treatment Type (2025-2034) 7.5.4.2. India Insomnia Market Size and Forecast, by Therapy (2025-2034) 7.5.4.3. India Insomnia Market Size and Forecast, by Drug Class (2025-2034) 7.5.4.4. India Insomnia Market Size and Forecast, by Distribution Channel (2025-2034) 7.5.5. Australia 7.5.5.1. Australia Insomnia Market Size and Forecast, by Treatment Type (2025-2034) 7.5.5.2. Australia Insomnia Market Size and Forecast, by Therapy (2025-2034) 7.5.5.3. Australia Insomnia Market Size and Forecast, by Drug Class (2025-2034) 7.5.5.4. Australia Insomnia Market Size and Forecast, by Distribution Channel (2025-2034) 7.5.6. Indonesia 7.5.6.1. Indonesia Insomnia Market Size and Forecast, by Treatment Type (2025-2034) 7.5.6.2. Indonesia Insomnia Market Size and Forecast, by Therapy (2025-2034) 7.5.6.3. Indonesia Insomnia Market Size and Forecast, by Drug Class (2025-2034) 7.5.6.4. Indonesia Insomnia Market Size and Forecast, by Distribution Channel (2025-2034) 7.5.7. Malaysia 7.5.7.1. Malaysia Insomnia Market Size and Forecast, by Treatment Type (2025-2034) 7.5.7.2. Malaysia Insomnia Market Size and Forecast, by Therapy (2025-2034) 7.5.7.3. Malaysia Insomnia Market Size and Forecast, by Drug Class (2025-2034) 7.5.7.4. Malaysia Insomnia Market Size and Forecast, by Distribution Channel (2025-2034) 7.5.8. Vietnam 7.5.8.1. Vietnam Insomnia Market Size and Forecast, by Treatment Type (2025-2034) 7.5.8.2. Vietnam Insomnia Market Size and Forecast, by Therapy (2025-2034) 7.5.8.3. Vietnam Insomnia Market Size and Forecast, by Drug Class (2025-2034) 7.5.8.4. Vietnam Insomnia Market Size and Forecast, by Distribution Channel (2025-2034) 7.5.9. Taiwan 7.5.9.1. Taiwan Insomnia Market Size and Forecast, by Treatment Type (2025-2034) 7.5.9.2. Taiwan Insomnia Market Size and Forecast, by Therapy (2025-2034) 7.5.9.3. Taiwan Insomnia Market Size and Forecast, by Drug Class (2025-2034) 7.5.9.4. Taiwan Insomnia Market Size and Forecast, by Distribution Channel (2025-2034) 7.5.10. Rest of Asia Pacific 7.5.10.1. Rest of Asia Pacific Insomnia Market Size and Forecast, by Treatment Type (2025-2034) 7.5.10.2. Rest of Asia Pacific Insomnia Market Size and Forecast, by Therapy (2025-2034) 7.5.10.3. Rest of Asia Pacific Insomnia Market Size and Forecast, by Drug Class (2025-2034) 7.5.10.4. Rest of Asia Pacific Insomnia Market Size and Forecast, by Distribution Channel (2025-2034) 8. Middle East and Africa Insomnia Market Size and Forecast by Segmentation (in USD Billion) 2025-2034 8.1. Middle East and Africa Insomnia Market Size and Forecast, by Treatment Type (2025-2034) 8.2. Middle East and Africa Insomnia Market Size and Forecast, by Therapy (2025-2034) 8.3. Middle East and Africa Insomnia Market Size and Forecast, by Drug Class (2025-2034) 8.4. Middle East and Africa Insomnia Market Size and Forecast, by Distribution Channel (2025-2034) 8.5. Middle East and Africa Insomnia Market Size and Forecast, by Country (2025-2034) 8.5.1. South Africa 8.5.1.1. South Africa Insomnia Market Size and Forecast, by Treatment Type (2025-2034) 8.5.1.2. South Africa Insomnia Market Size and Forecast, by Therapy (2025-2034) 8.5.1.3. South Africa Insomnia Market Size and Forecast, by Drug Class (2025-2034) 8.5.1.4. South Africa Insomnia Market Size and Forecast, by Distribution Channel (2025-2034) 8.5.2. GCC 8.5.2.1. GCC Insomnia Market Size and Forecast, by Treatment Type (2025-2034) 8.5.2.2. GCC Insomnia Market Size and Forecast, by Therapy (2025-2034) 8.5.2.3. GCC Insomnia Market Size and Forecast, by Drug Class (2025-2034) 8.5.2.4. GCC Insomnia Market Size and Forecast, by Distribution Channel (2025-2034) 8.5.3. Nigeria 8.5.3.1. Nigeria Insomnia Market Size and Forecast, by Treatment Type (2025-2034) 8.5.3.2. Nigeria Insomnia Market Size and Forecast, by Therapy (2025-2034) 8.5.3.3. Nigeria Insomnia Market Size and Forecast, by Drug Class (2025-2034) 8.5.3.4. Nigeria Insomnia Market Size and Forecast, by Distribution Channel (2025-2034) 8.5.4. Rest of ME&A 8.5.4.1. Rest of ME&A Insomnia Market Size and Forecast, by Treatment Type (2025-2034) 8.5.4.2. Rest of ME&A Insomnia Market Size and Forecast, by Therapy (2025-2034) 8.5.4.3. Rest of ME&A Insomnia Market Size and Forecast, by Drug Class (2025-2034) 8.5.4.4. Rest of ME&A Insomnia Market Size and Forecast, by Distribution Channel (2025-2034) 9. South America Insomnia Market Size and Forecast by Segmentation (in USD Billion) 2025-2034 9.1. South America Insomnia Market Size and Forecast, by Treatment Type (2025-2034) 9.2. South America Insomnia Market Size and Forecast, by Therapy (2025-2034) 9.3. South America Insomnia Market Size and Forecast, by Drug Class (2025-2034) 9.4. South America Insomnia Market Size and Forecast, by Distribution Channel (2025-2034) 9.5. South America Insomnia Market Size and Forecast, by Country (2025-2034) 9.5.1. Brazil 9.5.1.1. Brazil Insomnia Market Size and Forecast, by Treatment Type (2025-2034) 9.5.1.2. Brazil Insomnia Market Size and Forecast, by Therapy (2025-2034) 9.5.1.3. Brazil Insomnia Market Size and Forecast, by Drug Class (2025-2034) 9.5.1.4. Brazil Insomnia Market Size and Forecast, by Distribution Channel (2025-2034) 9.5.2. Argentina 9.5.2.1. Argentina Insomnia Market Size and Forecast, by Treatment Type (2025-2034) 9.5.2.2. Argentina Insomnia Market Size and Forecast, by Therapy (2025-2034) 9.5.2.3. Argentina Insomnia Market Size and Forecast, by Drug Class (2025-2034) 9.5.2.4. Argentina Insomnia Market Size and Forecast, by Distribution Channel (2025-2034) 9.5.3. Rest Of South America 9.5.3.1. Rest Of South America Insomnia Market Size and Forecast, by Treatment Type (2025-2034) 9.5.3.2. Rest Of South America Insomnia Market Size and Forecast, by Therapy (2025-2034) 9.5.3.3. Rest Of South America Insomnia Market Size and Forecast, by Drug Class (2025-2034) 9.5.3.4. Rest Of South America Insomnia Market Size and Forecast, by Distribution Channel (2025-2034) 10. Company Profile: Key Players 10.1. Pfizer Inc. 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Scale of Operation (small, medium, and large) 10.1.7. Details on Partnership 10.1.8. Regulatory Accreditations and Certifications Received by Them 10.1.9. Awards Received by the Firm 10.1.10. Recent Developments 10.2. Merck & Co. Inc. 10.3. Sanofi S.A. 10.4. GlaxoSmithKline plc 10.5. Takeda Pharmaceutical Company Limited 10.6. Koninklijke Philips N.V. 10.7. Viatris Inc. 10.8. Astellas Pharma Inc. 10.9. Sun Pharmaceutical Industries Limited 10.10. Eisai Co. Ltd. 10.11. Idorsia Ltd. 10.12. Teva Pharmaceutical Industries Ltd. 10.13. Dr. Reddy's Laboratories Ltd. 10.14. Big Health Ltd. 10.15. Vanda Pharmaceuticals Inc. 10.16. Sumitomo Pharma Co. Ltd. 10.17. Jazz Pharmaceuticals plc 10.18. Aurobindo Pharma Limited 10.19. Cipla Inc. 10.20. Zydus Lifesciences Limited 10.21. Lupin Limited 10.22. Mallinckrodt Pharmaceuticals 10.23. Fisher & Paykel Healthcare Corporation Limited 10.24. ResMed Inc. 10.25. Sunovion Pharmaceuticals Inc. 10.26. Casper Sleep Inc. 10.27. Biocodex Inc. 10.28. SleepScore Labs 10.29. Paratek Pharmaceuticals Inc. 10.30. Ebb Therapeutics 11. Key Findings 12. Industry Recommendations 13. Insomnia Market: Research Methodology 14. Terms and Glossary

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Request Customization Download Sample